Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data

In pheochromocytoma and paraganglioma (PPGL), germline or somatic mutations in one of the known susceptibility genes are identified in up to 60% patients. However, the peculiar genetic events that drive the aggressive behavior including metastasis in PPGL are poorly understood. We performed targeted...

Full description

Bibliographic Details
Main Authors: Yun Mi Choi, Jinyeong Lim, Min Ji Jeon, Yu-Mi Lee, Tae-Yon Sung, Eun-Gyoung Hong, Ji-Young Lee, Se Jin Jang, Won Gu Kim, Dong Eun Song, Sung-Min Chun
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/10/2389
_version_ 1797534058948853760
author Yun Mi Choi
Jinyeong Lim
Min Ji Jeon
Yu-Mi Lee
Tae-Yon Sung
Eun-Gyoung Hong
Ji-Young Lee
Se Jin Jang
Won Gu Kim
Dong Eun Song
Sung-Min Chun
author_facet Yun Mi Choi
Jinyeong Lim
Min Ji Jeon
Yu-Mi Lee
Tae-Yon Sung
Eun-Gyoung Hong
Ji-Young Lee
Se Jin Jang
Won Gu Kim
Dong Eun Song
Sung-Min Chun
author_sort Yun Mi Choi
collection DOAJ
description In pheochromocytoma and paraganglioma (PPGL), germline or somatic mutations in one of the known susceptibility genes are identified in up to 60% patients. However, the peculiar genetic events that drive the aggressive behavior including metastasis in PPGL are poorly understood. We performed targeted next-generation sequencing analysis to characterize the mutation profile in fifteen aggressive PPGL patients and compared accessible data of aggressive PPGLs from The Cancer Genome Atlas (TCGA) with findings of our cohort. A total of 115 germline and 34 somatic variants were identified with a median 0.58 per megabase tumor mutation burden in our cohort. The most frequent mutation was <i>SDHB</i> germline mutation (27%) and the second frequent mutations were somatic mutations for <i>SETD2</i>, <i>NF1</i>, and <i>HRAS</i> (13%, respectively). Patients were subtyped into three categories based on the kind of mutated genes: pseudohypoxia (<i>n</i> = 5), kinase (<i>n</i> = 5), and unknown (<i>n</i> = 5) group. In copy number variation analysis, deletion of chromosome arm 1p harboring <i>SDHB</i> gene was the most frequently observed. In our cohort, <i>SDHB</i> mutation and pseudohypoxia subtype were significantly associated with poor overall survival. In conclusion, subtyping of mutation profile can be helpful in aggressive PPGL patients with heterogeneous prognosis to make relevant follow-up plan and achieve proper treatment.
first_indexed 2024-03-10T11:24:15Z
format Article
id doaj.art-b9699b2f1ccc410797a79de9301f4c50
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T11:24:15Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-b9699b2f1ccc410797a79de9301f4c502023-11-21T19:49:48ZengMDPI AGCancers2072-66942021-05-011310238910.3390/cancers13102389Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA DataYun Mi Choi0Jinyeong Lim1Min Ji Jeon2Yu-Mi Lee3Tae-Yon Sung4Eun-Gyoung Hong5Ji-Young Lee6Se Jin Jang7Won Gu Kim8Dong Eun Song9Sung-Min Chun10Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Gyeonggi-Do 18450, KoreaAsan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, Seoul 05505, KoreaDepartment of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Gyeonggi-Do 18450, KoreaDepartment of Medical Science, Asan Medical Center, Asan Medical Institute of Convergence Science and Technology, University of Ulsan College of Medicine, Seoul 05505, KoreaAsan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, Seoul 05505, KoreaDepartment of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaDepartment of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, KoreaAsan Center for Cancer Genome Discovery, Asan Institute for Life Sciences, Seoul 05505, KoreaIn pheochromocytoma and paraganglioma (PPGL), germline or somatic mutations in one of the known susceptibility genes are identified in up to 60% patients. However, the peculiar genetic events that drive the aggressive behavior including metastasis in PPGL are poorly understood. We performed targeted next-generation sequencing analysis to characterize the mutation profile in fifteen aggressive PPGL patients and compared accessible data of aggressive PPGLs from The Cancer Genome Atlas (TCGA) with findings of our cohort. A total of 115 germline and 34 somatic variants were identified with a median 0.58 per megabase tumor mutation burden in our cohort. The most frequent mutation was <i>SDHB</i> germline mutation (27%) and the second frequent mutations were somatic mutations for <i>SETD2</i>, <i>NF1</i>, and <i>HRAS</i> (13%, respectively). Patients were subtyped into three categories based on the kind of mutated genes: pseudohypoxia (<i>n</i> = 5), kinase (<i>n</i> = 5), and unknown (<i>n</i> = 5) group. In copy number variation analysis, deletion of chromosome arm 1p harboring <i>SDHB</i> gene was the most frequently observed. In our cohort, <i>SDHB</i> mutation and pseudohypoxia subtype were significantly associated with poor overall survival. In conclusion, subtyping of mutation profile can be helpful in aggressive PPGL patients with heterogeneous prognosis to make relevant follow-up plan and achieve proper treatment.https://www.mdpi.com/2072-6694/13/10/2389aggressive pheochromocytomaparagangliomaDNA mutation analysishigh-throughput nucleotide sequencingprognosis
spellingShingle Yun Mi Choi
Jinyeong Lim
Min Ji Jeon
Yu-Mi Lee
Tae-Yon Sung
Eun-Gyoung Hong
Ji-Young Lee
Se Jin Jang
Won Gu Kim
Dong Eun Song
Sung-Min Chun
Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
Cancers
aggressive pheochromocytoma
paraganglioma
DNA mutation analysis
high-throughput nucleotide sequencing
prognosis
title Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
title_full Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
title_fullStr Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
title_full_unstemmed Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
title_short Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data
title_sort mutation profile of aggressive pheochromocytoma and paraganglioma with comparison of tcga data
topic aggressive pheochromocytoma
paraganglioma
DNA mutation analysis
high-throughput nucleotide sequencing
prognosis
url https://www.mdpi.com/2072-6694/13/10/2389
work_keys_str_mv AT yunmichoi mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT jinyeonglim mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT minjijeon mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT yumilee mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT taeyonsung mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT eungyounghong mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT jiyounglee mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT sejinjang mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT wongukim mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT dongeunsong mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata
AT sungminchun mutationprofileofaggressivepheochromocytomaandparagangliomawithcomparisonoftcgadata